Mitogenic action of LPA in prostate.
The lipid growth factor lysophosphatidic acid (LPA) elicits multiple cellular responses, including cell growth and survival. LPA acts upon target cells by activating its cognate receptors, which belong to the G protein-coupled endothelial differentiation gene (EDG) family. To date, three known LPA receptors, termed LPA1, LPA2 and LPA3, have been molecularly characterized and cloned. Here, we review recent data describing the molecular steps involved in the LPA receptor-mediated activation of mitogenic extracellular signal-regulated kinase (ERK) pathway in prostate cancer. Induction of ERK by LPA proceeds via Gbetagamma-dependent activation of tyrosine kinases, including the epidermal growth factor (EGF) receptor and c-Src. Further, LPA-induced ERK activation involves matrix metalloproteinases (MMPs), which cause the release of active EGFR ligands. Finally, we present data demonstrating a correlation between the mitogenic effects of LPA and expression of the lp(A1) gene in the prostate cancer cells.
Daaka
Yehia
Y
Department of Surgery, Duke University Medical Center, DUMC 2607, Durham, NC 27710, USA. daaka001@duke.edu
D000818:Animals; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D008246:Lysophospholipids / Q000502:physiology*; D020935:MAP Kinase Signaling System / Q000502:physiology; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D011467:Prostate / Q000166:cytology* / Q000502:physiology*
D006133:Growth Substances; D008246:Lysophospholipids; D020928:Mitogen-Activated Protein Kinases